(E)-1-(4-chlorophenyl)-3-(2-hydroxy-3-methoxyphenyl)prop-2-en-1-one | 934022-19-2

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-1-(4-chlorophenyl)-3-(2-hydroxy-3-methoxyphenyl)prop-2-en-1-one
• 英文别名: (2E)-1-(4-chlorophenyl)-3-(2-hydroxy-3-methoxyphenyl)prop-2-en-1-one
• CAS: 934022-19-2
• 化学式: C₁₆H₁₃ClO₃
• 分子量: 288.73
• InChiKey: DYKSORHKUYMVFH-JXMROGBWSA-N

物化性质

• 熔点：
  129-131 °C
• 沸点：
  460.0±45.0 °C(Predicted)
• 密度：
  1.287±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  邻乙酰水杨酰氯 、 (E)-1-(4-chlorophenyl)-3-(2-hydroxy-3-methoxyphenyl)prop-2-en-1-one 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 12.0h， 生成 (E)-2-(3-(4-chlorophenyl)-3-oxoprop-1-en-1-yl)-6-methoxyphenyl 2-acetoxybenzoate
  参考文献：
  名称：

  源自阿司匹林和查尔酮的新型杂交体可在体外和体内有效抑制结直肠癌†

  摘要：

  尽管有许多经批准的小分子可用于治疗，但结直肠癌 (CRC) 仍然是全球癌症死亡的第四大原因。问题在于这些化合物的效力、选择性和靶向性。因此，需要新的策略和目标来优化和开发新的 CRC 治疗方法。在这里，根据最近关于它们对 CRC 靶向和选择性的益处的报道，设计和合成了一组源自阿司匹林和查耳酮的新型杂合体。与目前用于 CRC 的治疗剂 5-氟尿嘧啶相比，最活跃的化合物7h抑制 CRC 细胞系的增殖具有更好的效力。重要的是，7h对非癌 CCD841 细胞的抑制活性降低了 8 倍。此外，7h通过抑制 G1 期的细胞周期来抑制 CRC 生长。此外，7h通过激活 caspase 3 和 PARP 切割以及增加 CRC 细胞中的 ROS 来诱导细胞凋亡。最后，7h显着延缓了小鼠异种移植模型中的 CRC 细胞生长。这些发现表明7h可能具有治疗 CRC 的潜力。

  DOI：

  10.1039/c8md00284c
• 作为产物：
  描述：

  2'-溴-4-氯苯乙酮 以 四氢呋喃 、 甲苯 为溶剂， 反应 36.0h， 生成 (E)-1-(4-chlorophenyl)-3-(2-hydroxy-3-methoxyphenyl)prop-2-en-1-one
  参考文献：
  名称：

  源自阿司匹林和查尔酮的新型杂交体可在体外和体内有效抑制结直肠癌†

  摘要：

  尽管有许多经批准的小分子可用于治疗，但结直肠癌 (CRC) 仍然是全球癌症死亡的第四大原因。问题在于这些化合物的效力、选择性和靶向性。因此，需要新的策略和目标来优化和开发新的 CRC 治疗方法。在这里，根据最近关于它们对 CRC 靶向和选择性的益处的报道，设计和合成了一组源自阿司匹林和查耳酮的新型杂合体。与目前用于 CRC 的治疗剂 5-氟尿嘧啶相比，最活跃的化合物7h抑制 CRC 细胞系的增殖具有更好的效力。重要的是，7h对非癌 CCD841 细胞的抑制活性降低了 8 倍。此外，7h通过抑制 G1 期的细胞周期来抑制 CRC 生长。此外，7h通过激活 caspase 3 和 PARP 切割以及增加 CRC 细胞中的 ROS 来诱导细胞凋亡。最后，7h显着延缓了小鼠异种移植模型中的 CRC 细胞生长。这些发现表明7h可能具有治疗 CRC 的潜力。

  DOI：

  10.1039/c8md00284c

文献信息

• Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans
  作者：D. Batovska、St. Parushev、A. Slavova、V. Bankova、I. Tsvetkova、M. Ninova、H. Najdenski

  DOI：10.1016/j.ejmech.2006.08.012

  日期：2007.1

  A large series of chalcones were synthesized and studied for activity against Candida albicans. The SAR analysis showed that the antifungal activity was highly dependent on the substitution pattern of the aryl rings and correlated to a large extent with the ability of compounds to interact with sulfhydryl groups. The most active were the hydroxylated chalcones as their activity related to the location

  合成了大量查耳酮，并研究了其对白色念珠菌的活性。SAR分析表明，抗真菌活性高度依赖于芳基环的取代方式，并在很大程度上与化合物与巯基相互作用的能力有关。最具活性的是羟基化查耳酮，因为它们的活性与芳基环B中酚基的位置有关，如下所示：o-OH> p-OH约为3,4-di-OH> m-OH。获得的这些相关性和其他相关性极大地有助于设计抗候选查耳酮。
• Facile Synthesis of Aryl-Substituted 1,2,5,6-Tetrahydropyrimidines and Their Stereochemical Investigation
  作者：Valentin A. Chebanov、Elena A. Muravyova、Yulia V. Sadchikova、Sergey M. Desenko、Vitaly N. Chernenko、Kiril M. Kobzar、Vladimir I. Musatov

  DOI：10.1135/cccc20040897

  日期：——

  The present work is devoted to the investigation of 2,4,6-triaryl-1,2,5,6-tetrahydropyrimidine derivatives. A new facile approach to their synthesis based on the reaction of α,β-unsaturated ketones, carbonyl compounds and ammonia was developed. Some stereochemical features of the compounds obtained were fixed on the base of NMR data (including COSY and NOESY experiments).

  这项工作致力于研究2,4,6-三芳基-1,2,5,6-四氢嘧啶衍生物。基于α,β-不饱和酮、羰基化合物和氨的反应开发了一种新的简便合成方法。根据核磁共振数据（包括COSY和NOESY实验），确定了所得化合物的一些立体化学特征。
• Antifungal activity of chalcones: A mechanistic study using various yeast strains
  作者：K.L. Lahtchev、D.I. Batovska、St.P. Parushev、V.M. Ubiyvovk、A.A. Sibirny

  DOI：10.1016/j.ejmech.2007.12.027

  日期：2008.10

  We reported the synthesis, antifungal evaluation and study on substituent effects of 21 chalcones. A lot of genetically defined strains belonging to different yeast genera and species, namely Saccharomyces cerevisiae, Hansenula polymorpha and Kluyveromyces lactis, were used as test organisms. Concerning the mode of the antifungal action of chalcones it was shown that DNA was probably not the main target for the chalcones. It was revealed that the yeast's intracellular glutathione and cysteine molecules play significant role as defence barrier against the chalcone action. It was also shown that chalcones may react with some proteins involved in cell separation. (C) 2008 Elsevier Masson SAS. All fights reserved.
• Compounds exhibiting efflux inhibitor activity and composition and uses thereof
  申请人：Wempe Fitzpatrick Michael

  公开号：US20070254859A1

  公开（公告）日：2007-11-01

  At least one compound chosen from compounds of Formula I: a pharmaceutically acceptable salt or ester thereof, a solvate thereof, a chelate thereof, a non-covalent complex thereof, a prodrug thereof, and mixtures of any of the foregoing, wherein: n is a number from 1 to 900, wherein the individual units may be the same or different; W is chosen from alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, aralkyl and substituted aralkyl; each of R 2 , R 3 , R 4 and R 5 is independently chosen from —H, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, aralkyl and substituted aralkyl; Z′ is chosen from —O—, —N—, —NO—, —NR 4 —, —S—, —SO— and —SO 2 —, wherein R 4 is defined as above; each of X, X′, Y and Z is independently chosen from —CR 4 R 5 —, —NH—, —NR 4 —, —NO—, —O—, —NOR 4 —, —S—, —SO—, —SO 2 —, wherein R 4 and R 5 are defined as above; R 1 is chosen from a tocopherol, a steroid and a flavonoid; and R 6 is chosen from any R 1 , alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, aralkyl and substituted aralkyl.
• ESTROGEN RECEPTOR ALPHA COLIGANDS, AND METHODS OF USE THEREOF
  申请人：The Regents of the University of California

  公开号：US20190008797A1

  公开（公告）日：2019-01-10

  Provided herein is a coligand for the estrogen receptor (ER) a subunit, and methods of use thereof in treating conditions associated with ER signaling in an individual. The present ERα coligand may be a cell type-selective, allosteric modulator of ERα signaling. The ERα coligand, when administered to an individual, may modulate ER agonist-dependent signaling in a tissue-selective manner.